| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |